SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "onr:"swepub:oai:gup.ub.gu.se/231696" "

Sökning: onr:"swepub:oai:gup.ub.gu.se/231696"

  • Resultat 1-1 av 1
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Heslegrave, Amanda, et al. (författare)
  • Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease.
  • 2016
  • Ingår i: Molecular neurodegeneration. - : BioMed Central (BMC). - 1750-1326. ; 11
  • Tidskriftsartikel (refereegranskat)abstract
    • The discovery that heterozygous missense mutations in the gene encoding triggering receptor expressed on myeloid cells 2 (TREM2) are risk factors for Alzheimer's disease (AD), with only the apolipoprotein E (APOE) ε4 gene allele conferring a higher risk, has led to increased interest in immune biology in the brain. TREM2 is expressed on microglia, the resident immune cells of the brain and has been linked to phagocytotic clearance of amyloid β (Aβ) plaques. Soluble TREM2 (sTREM2) has previously been measured in cerebrospinal fluid (CSF) by ELISA but in our hands commercial kits have proved unreliable, suggesting that other methods may be required. We developed a mass spectrometry method using selected reaction monitoring for the presence of a TREM2 peptide, which can be used to quantify levels of sTREM2 in CSF.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-1 av 1
 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy